Bank of Montreal
SNDX icon

Bank of Montreal’s Syndax Pharmaceuticals SNDX Stock Holding History

Bank of Montreal’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$356K Buy
+15,242
New +$331K ﹤0.01% 2563
2021
Q2 		– Sell
-2,256
Closed -$52K – 4782
2021
Q1 		$52K Sell
2,256
-3,705
-62% -$83.7K ﹤0.01% 3681
2020
Q4 		$141K Buy
5,961
+2,913
+96% +$60.4K ﹤0.01% 3400
2020
Q3 		$51K Sell
3,048
-914
-23% -$13.9K ﹤0.01% 3420
2020
Q2 		$61K Buy
3,962
+2,074
+110% +$31.6K ﹤0.01% 3334
2020
Q1 		$18K Sell
1,888
-2,789
-60% -$26.2K ﹤0.01% 3295
2019
Q4 		$41K Buy
4,677
+792
+20% +$5.82K ﹤0.01% 3941
2019
Q3 		$29K Buy
3,885
+61
+2% +$556 ﹤0.01% 3884
2019
Q2 		$36K Buy
+3,824
New +$27.9K ﹤0.01% 3842
2019
Q1 		– Sell
-189
Closed -$1K – 4703
2018
Q4 		$1K Buy
189
+93
+97% +$510 ﹤0.01% 4558
2018
Q3 		$1K Sell
96
-9
-9% -$64 ﹤0.01% 4595
2018
Q2 		$1K Buy
+105
New +$1.03K ﹤0.01% 4585
2017
Q3 		– Sell
-11,329
Closed -$158K – 4310
2017
Q2 		$158K Buy
+11,329
New +$130K ﹤0.01% 2772

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Bank of Montreal's SNDX Position: Q1 2026 in Review

Bank of Montreal opened a new position in Syndax Pharmaceuticals (SNDX) in Q1 2026: 15,242 shares worth $356K. The stake represents ﹤0.01% of the portfolio and ranks #2563 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in SNDX as recently as Q1 2021.

Bank of Montreal first reported a position in SNDX in Q2 2017 and has held it in 13 quarters since. 247 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Bank of Montreal held 15,242 shares of Syndax Pharmaceuticals worth $356K as of Q1 2026.
  • Syndax Pharmaceuticals was a new Bank of Montreal position in Q1 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2563 holding.
  • Bank of Montreal first reported a position in Syndax Pharmaceuticals in Q2 2017 and has held it in 13 quarters since.
  • 247 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.